Priligy effective for treatment of premature ejaculation in Korean people

Published: 2009-08-17 06:58:00

Updated: 2009-08-17 06:58:00

Janssen Korea announced on August 12 the positive outcome of Priligy (dapoxetine) in 520 Korean people with premature ejaculation (PE) who participated in a clinical trial from April 2005 to 2006.

“The safety and efficacy of Priligy have been demonstrated in Korean people in terms of three maj...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK